Clinical TrialsSearch results
Number of results: 482
Completed
- Effect of Semaglutide 2.4 mg once-weekly on function and symptoms in subjects with obesity-related heart failure with preserved ejection fraction, and type 2 diabetes
- Type2 diabetes and obesity-related heart failure with preserved ejection fraction
- Kinoshita Kazunori
- 2021-06-17
Recruiting
- Effect of single-drug treatment on acute low-tone sensorineural hearing loss
- acute low-tone sensorineural hearing loss
- Ministry of Health, Labour and Welfare
- 2009-08-15
Other
- Effectiveness of zinc acetate hydrate supplementation in chronic kidney disease patients
- chronic kidney disease
- Itano Seiji
- 2021-08-27
Other
- Effects of falecalcitoriol on post-operative hypoparathyroidism after thyroidectomy
- Postoperative hypoparathyroidism
- kawasaki medicak school
- 2009-07-06
Recruiting
- Effects of hydrogen jelly on depressive symptoms and cognitive function
- Mild cognitive impairment, Depression in the elderly
- Takayuki Maruyama
- 2023-08-02
Other
- Effects of modifications of CKD care systems at general practice physicians on cooperation with nephrologists and outcome of CKD patients.
- chronic kidney disease
- University of Tsukuba
- 2008-05-16
Recruiting
- Effects of tastant on salivation flow.
- Xerostomia
- HIKARU SUGIMOTO
- 2021-10-01
Not yet recruiting
- Effects of ziltivekimab versus placebo on cardiovascular outcomes in patients with acute myocardial infarction
- acute myocardial infarction
- Okada Takumi
- 2024-05-17
Other
- Efficacy and Safety of mizoribine for MPO-ANCA associated vasculitis; A multicenter randomized controlled trial (Mizoribin for ANCA RPGN Relapse-Prevention study:MARPGN study)
- MPO-ANCA associated vasculitis
- Department of Nephrology, Division of Clinical Sciences, Faculty of Medicine, University of Tsukuba
- 2007-05-06
Recruiting
- Efficacy and safety of NNC6019-0001 at two dose levels in participants with transthyretin amyloid cardiomyopathy (ATTR CM)(NN6019-4940)
- transthyretin amyloid cardiomyopathy (hATTR CM or wtATTR CM)
- Ito Junji
- 2023-06-21